---
title: "toxicity_in_majestec-1"
date: "2024-08-24"
tags:
  - building
---

> [!NOTE]
> ðŸŒ± created from: [[majestec-1]]

# toxicity_in_majestec-1

| Parameter           | Details                         |
| ------------------- | ------------------------------- |
| CRS Patients        | 119 (72.1%)                     |
| Timing              | after step-up and cycle 1       |
| Severity            | Grade 1/2, 1 Grade 3 (resolved) |
| Discontinuation     | None                            |
| Median Onset        | 2 days (range: 1-6)             |
| Median Duration     | 2 days (range: 1-9)             |
| Supportive Measures | 110 (66.7%)                     |
| Tocilizumab         | 60 (36.4%)                      |
| Low-Flow Oxygen     | 21 (12.7%)                      |
| Glucocorticoids     | 14 (8.5%)                       |
| Vasopressor         | 1 (0.6%)                        |
